机器学习驱动的混合性结缔组织病免疫表型分层,印证其临床异质性
基于ImmuNexUT功能基因组数据库,用SLE、IIM和SSc患者免疫表型数据训练随机森林等机器学习模型,对22例MCTD患者进行分层,16例归为SLE免疫表型、6例归为非SLE免疫表型。SLE免疫表型者Th1细胞和浆母细胞比例更高、SLE相关症状数更多,干扰素α和γ反应GSVA评分在中央记忆CD8+ T细胞中显著更高,提示MCTD临床亚型背后存在不同免疫学过程。
要点
- 机器学习将22例MCTD分为SLE免疫表型16例与非SLE免疫表型6例。
- SLE免疫表型者Th1细胞2.85% vs 1.33%、浆母细胞6.35% vs 2.00%,均更高。
- SLE免疫表型者SLE相关症状数2.0 vs 1.0,干扰素α和γ反应评分在中央记忆CD8+ T细胞中更高。
核心结论
- 本研究基于免疫表型对MCTD患者进行分层,提示MCTD临床亚型背后存在不同的免疫学过程。
研究设计与样本
- 分析ImmuNexUT功能基因组数据库中24个免疫细胞亚群的免疫表型与转录组,纳入215例患者(含22例MCTD、SLE、IIM和SSc)。
- 以SLE、IIM和SSc患者免疫表型数据训练随机森林等机器学习模型,用于对MCTD患者分层。
- 转录组采用基因集变异分析(GSVA),并比较MCTD亚组临床特征。
主要发现
- 机器学习模型将22例MCTD患者分为SLE免疫表型16例与非SLE免疫表型6例。
- SLE免疫表型MCTD患者Th1细胞比例2.85%(IQR 1.54-3.91)vs 非SLE免疫表型1.33%(IQR 0.99-1.74),P=0.027。
- SLE免疫表型MCTD患者浆母细胞比例6.35%(IQR 4.17-17.49)vs 非SLE免疫表型2.00%(IQR 1.20-2.80),P=0.010。
- SLE免疫表型MCTD患者SLE相关症状数2.0(IQR 1.0-2.0)vs 非SLE免疫表型1.0(IQR 1.0-1.0),P=0.038。
- SLE免疫表型MCTD患者中央记忆CD8+ T细胞的干扰素α和γ反应GSVA评分显著更高,非SLE免疫表型者在五个细胞亚群中hedgehog信号更高。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The objective of this study was to stratify patients with MCTD, based on their immunophenotype. METHODS: We analysed the immunophenotype and transcriptome of 24 immune cell subsets [from patients with MCTD, SLE, idiopathic inflammatory myopathy (IIM) and SSc] from our functional genome database, ImmuNexUT (https://www.immunexut.org/). MCTD patients were stratified by employing machine-learning models, including Random Forest, trained by immunophenotyping data from SLE, IIM and SSc patients. The transcriptomes were analysed with gene set variation analysis (GSVA), and the clinical features of the MCTD subgroups were compared. RESULTS: This study included 215 patients, including 22 patients with MCTD. Machine-learning models, constructed to classify SLE, IIM and SSc patients, based on immunophenotyping, were applied to MCTD patients, resulting in 16 patients being classified as having an SLEimmunophenotype and 6 as having a non-SLE immunophenotype. Among the MCTD patients, patients with the SLE immunophenotype had higher proportions of Th1 cells {2.85% [interquartile range (IQR) 1.54-3.91] vs 1.33% (IQR 0.99-1.74) P = 0.027} and plasmablasts [6.35% (IQR 4.17-17.49) vs 2.00% (IQR 1.20-2.80) P = 0.010]. Notably, the number of SLE-related symptoms was higher in patients with the SLE immunophenotype [2.0 (IQR 1.0-2.0) vs 1.0 (IQR 1.0-1.0) P = 0.038]. Moreover, the GSVA scores of interferon-α and -γ responses were significantly higher in patients with the SLE immunophenotype in central memory CD8+ T cells, while hedgehog signalling was higher in patients with the non-SLE immunophenotype, in five-cell subsets. CONCLUSION: This study describes the stratification of MCTD patients, based on immunophenotyping, suggesting the presence of distinct immunological processes behind the clinical subtypes of MCTD.
引用
- Izuka S, Komai T, Itamiya T, et al. Machine learning-driven immunophenotypic stratification of mixed connective tissue disease, corroborating the clinical heterogeneity. Rheumatology (Oxford). 2025. PMID: 38479808. doi:10.1093/rheumatology/keae158
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。